Xuan Chen
Impact in
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Mesenchymal stem cell research
Papers in
- Surgery 13
- Bladder and Urothelial Cancer Treatments 5
- Esophageal Cancer Research and Treatment 2
-
- Epigenetics and DNA Methylation 4
- Co-authors
- Xin Lü (2 shared papers)Yuan Yin (2 shared papers)Changli Tao (2 shared papers)Chang Zhou (1 shared paper)Yufeng Cheng (4 shared papers)Xue Chen (3 shared papers)Huaping Li (1 shared paper)Yajuan Huang (1 shared paper)
- Journals
- Andrologia (2 papers)Advanced Healthcare Materials (1 paper)The Spine Journal (1 paper)International Immunopharmacology (1 paper)Phytomedicine (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Xuan Chen
35 papers receiving 279 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 63
- Genetics 29
- Oncology 48
- Molecular Biology 115
- Surgery 54
Countries citing papers authored by Xuan Chen
This map shows the geographic impact of Xuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Chen more than expected).
Fields of papers citing papers by Xuan Chen
This network shows the impact of papers produced by Xuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Chen. The network helps show where Xuan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 51 | |
| 2 | 2022 | 20 | |
| 3 | Acute pancreatitis in pregnancy: a 6-year single center clinical experience. | 2011 | 19 |
| 4 | 2019 | 18 | |
| 5 | The clinical significance of isocitrate dehydrogenase 2 in esophageal squamous cell carcinoma. | 2017 | 18 |
| 6 | 2020 | 17 | |
| 7 | 2019 | 15 | |
| 8 | 2022 | 11 | |
| 9 | 2016 | 11 | |
| 10 | 2023 | 10 | |
| 11 | 2013 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2018 | 9 | |
| 14 | 2008 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2015 | 4 | |
| 20 | 2018 | 4 |
About Xuan Chen
Xuan Chen is a scholar working on Surgery, Molecular Biology, Oncology, Cancer Research and Pharmacology, having authored 36 papers that have together received 281 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Esophageal Cancer Research and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Cancer Research (63 citations), Genetics (29 citations), Oncology (48 citations), Molecular Biology (115 citations) and Surgery (54 citations). Xuan Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xin Lü, Yuan Yin, Changli Tao, Chang Zhou, Yufeng Cheng, Xue Chen, Huaping Li, Yajuan Huang, Wenzhe Xu and Di Huang. Their work appears in journals such as Andrologia, Advanced Healthcare Materials, The Spine Journal, International Immunopharmacology and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.